An Observational Study of Clinical Recurrence in Patients with Interstitial Lung Disease Related to the Antisynthetase Syndrome

Haoran Chen,Huarui Liu,Wenting Lyu,Yin Liu,Mei Huang,Yingwei Zhang,Yuying Qiu,Yonglong Xiao,Hourong Cai,Jinghong Dai
DOI: https://doi.org/10.1007/s10067-022-06424-4
2023-01-01
Clinical Rheumatology
Abstract:To describe the clinical characteristics and risk factors of clinical recurrence in interstitial lung disease related to antisynthetase syndrome (ARS-ILD). Patients diagnosed as ARS-ILD in Nanjing Drum Tower Hospital between January 2015 and November 2020 were retrospectively analyzed. Clinical information and treatment course were reviewed. The primary endpoint was the disease recurrence, and the secondary point was mortality. Univariate and multivariable Cox regression analyses were performed to identify risk factors for recurrence. Totally, 132 patients with ARS-ILD received immunomodulation treatment from diagnosis. During follow-ups, sixty-nine patients showed recurrence, with a recurrency rate yielding 52.3
What problem does this paper attempt to address?